{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-084242","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-07-16T20:05:45+00:00","discovered_at":"2026-07-16T20:07:00.304056+00:00","generated_at":"2026-07-16T20:07:09.932302+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Outlook Therapeutics stockholders approve authorized share increase and reverse split","bullets":["Authorized common stock increased from 260M to 600M shares via Certificate of Amendment filed July 16, 2026.","Reverse stock split approved at ratio 1:10 to 1:50, with exact ratio to be set by board of directors.","Stockholders approved issuance of shares underlying warrants from April 2026 private placement (up to 16.1M shares) and placement agent warrants.","Special meeting quorum was 51.5% (62.3M of 120.9M outstanding shares present or represented).","Proposal 2 (authorized share increase) passed with 24.4M for, 8.7M against; Proposal 3 (reverse split) passed with 44.3M for, 17.8M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-084242","json":"https://secwatch.observer/filing/0001104659-26-084242.json","markdown":"https://secwatch.observer/filing/0001104659-26-084242.md","text":"https://secwatch.observer/filing/0001104659-26-084242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926084242/0001104659-26-084242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926084242/tm2620677d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T20:07:09.932302+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}